The forecasted data for stomach malignant neoplasms mortality in the US indicates a decline from 4.1 male deaths per hundred thousand men in 2024 to 3.8 in 2028. With no exact data from 2023 provided, we assume a similar rate to 2024, suggesting a consistent downward trend. On a year-on-year basis, a reduction is evident, with a slight 2.4% decline from 2024 to 2025, and smaller decreases continue through to 2028. The compound annual growth rate (CAGR) over these forecasted years shows an average annual decrease, highlighting an encouraging trend in mortality reduction.

Future trends to watch for:

Advancements in medical technology and early detection methods, which can further contribute to declining mortality rates.
Changes in lifestyle and dietary habits that might impact stomach cancer incidences.
Potential policy changes in healthcare that enhance access to cancer treatment.